文档简介
1、 HYPERLINK https:/www.MedChemE/Targets/YAP.html YAPYes-associated proteinYAP (Yes-associated protein) is a transcription co-activator in the Hippo tumor suppressor pathway and controls cell growth, tissuehomeostasis and organ size. YAP is inhibited by the kinase Lats, which phosphorylates YAP to ind
2、uce its cytoplasmic localizationand proteasomal degradation. YAP induces gene expression by binding to the TEAD family transcription factors.The function of YAP in human cancer is complex and could be cell-type-dependent. For instance, YAP could function as a tumorsuppressor in some cell types, such
3、 as hematological cancers, by inducing apoptosis in response to DNA damage.www.MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/YAP.html YAP HYPERLINK https:/www.MedChemE/Targets/YAP.html HYPERLINK https:/www.MedChemE/Targets/YAP.html Inhibitors, HYPERLINK https:/www.MedChemE/Targets/YAP.html HYPERL
4、INK https:/www.MedChemE/Targets/YAP.html Antagonists, HYPERLINK https:/www.MedChemE/Targets/YAP.html HYPERLINK https:/www.MedChemE/Targets/YAP.html Activators HYPERLINK https:/www.MedChemE/Targets/YAP.html HYPERLINK https:/www.MedChemE/Targets/YAP.html & HYPERLINK https:/www.MedChemE/Targets/YAP.htm
5、l HYPERLINK https:/www.MedChemE/Targets/YAP.html Modulators HYPERLINK https:/www.MedChemE/AICAR.html AICAR(Acadesine; AICA Riboside) Cat. No.: HY-13417 HYPERLINK https:/www.MedChemE/AICAR-phosphate.html AICAR HYPERLINK https:/www.MedChemE/AICAR-phosphate.html HYPERLINK https:/www.MedChemE/AICAR-phos
6、phate.html phosphate(Acadesine phosphate; AICA Riboside phosphate) Cat. No.: HY-13417AAICAR (Acadesine) is an adenosine analog and aAMPK activator. AICAR regulates the glucose andlipid metabolism, and inhibits proinflammatorycytokines and iNOS production. AICAR is also anautophagy, YAP and mitophagy
7、 inhibitor.AICAR phosphate (Acadesine phosphate) is anadenosine analog and a AMPK activator. AICARphosphate regulates the glucose and lipidmetabolism, and inhibits proinflammatory cytokinesand iNOS production. AICAR phosphate is also anautophagy, YAP and mitophagy inhibitor.Purity: 99.92%Clinical Da
8、ta: Phase 3Size: 50 mg, 100 mg, 200 mg, 500 mgPurity: 99.49%Clinical Data: Phase 3Size: 10 mM 1 mL, 50 mg, 100 mg, 200 mg, 500 mg HYPERLINK https:/www.MedChemE/cytochalasin-d.html Cytochalasin HYPERLINK https:/www.MedChemE/cytochalasin-d.html HYPERLINK https:/www.MedChemE/cytochalasin-d.html D(Zygos
9、porin A; NSC 209835) Cat. No.: HY-N6682 HYPERLINK https:/www.MedChemE/k-975.html K-975Cat. No.: HY-138565Cytochalasin D (Zygosporin A; NSC 209835) is apotent and cell-permeable inhibitor of actinpolymerization derived from fungus, inhibits theG-actincofilin interaction by binding to G-actin.K-975 is
10、 a potent, selective and orally activeTEAD inhibitor, with a strong inhibitory effectagainst protein-protein interactions betweenYAP1/TAZ and TEAD. K-975 covalently binds toCys359 located in the palmitate-binding pocket ofTEAD via an acrylamide structure.Purity: 99.75%Clinical Data: No Development R
11、eportedSize: 10 mM 1 mL, 1 mg, 5 mg, 10 mgPurity: 98.55%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/lats-in-1.html Lats-IN-1 HYPERLINK https:/www.MedChemE/lats-in-1.html HYPERLINK https:/www.MedChemE/ML-7-hydrochloride.html ML-7 HYPERLI
12、NK https:/www.MedChemE/ML-7-hydrochloride.html HYPERLINK https:/www.MedChemE/ML-7-hydrochloride.html hydrochlorideCat. No.: HY-138489 Cat. No.: HY-15417Lats-IN-1 is a potent and ATP-competitiveinhibitor of Lats1 and Lats2 kinases. Lats-IN-1promotes Yap-dependent proliferation inpostmitotic mammalian
13、 tissues.ML-7 hydrochloride is a naphthalene sulphonamidederivative, potently inhibits MLCK (IC =30050nM). ML-7 hydrochloride also inhibits YAP/TAZ.Purity: 99.98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 99.75%Clinical Data: No Development ReportedSize: 10
14、mM 1 mL, 10 mg, 50 mg HYPERLINK https:/www.MedChemE/myf-01-37.html MYF-01-37 HYPERLINK https:/www.MedChemE/myf-01-37.html HYPERLINK https:/www.MedChemE/py-60.html PY-60Cat. No.: HY-139603 Cat. No.: HY-141644MYF-01-37 is a covalent TEAD inhibitor targetingCys380. MYF-01-37 has a reversible inhibition
15、 onYAP/TEAD interaction.PY-60 is a robust and specific activator of YAPtranscriptional activity that targets annexin A2(ANXA2) with a K of 1.4 M. PY-60 directlydbinds to ANXA2 and antagonizes its normal cellularfunction of repressing YAP activity.Purity: 98.98%Clinical Data: No Development ReportedS
16、ize: 5 mg, 10 mg, 50 mg, 100 mgPurity: 98.63%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/super-tdu.html Super-TDU HYPERLINK https:/www.MedChemE/super-tdu.html HYPERLINK https:/www.MedChemE/super-tdu-1-31.html Super-TDU HYPER
17、LINK https:/www.MedChemE/super-tdu-1-31.html HYPERLINK https:/www.MedChemE/super-tdu-1-31.html (1-31)Cat. No.: HY-P1727 Cat. No.: HY-P1728Super-TDU is a specific YAP antagonist targetingYAP-TEADs interaction. Super-TDU suppresses tumorgrowth in gastric cancer mouse model.Super-TDU (1-31) is a peptid
18、e of Super-TDU, whichis an inhibitor of YAP-TEADs, shows potentanti-tumor activity.Purity: 98.85%Clinical Data: No Development ReportedSize: 10 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/
19、super-tdu-1-31-tfa.html Super-TDU HYPERLINK https:/www.MedChemE/super-tdu-1-31-tfa.html HYPERLINK https:/www.MedChemE/super-tdu-1-31-tfa.html (1-31) HYPERLINK https:/www.MedChemE/super-tdu-1-31-tfa.html HYPERLINK https:/www.MedChemE/super-tdu-1-31-tfa.html (TFA) HYPERLINK https:/www.MedChemE/super-t
20、du-1-31-tfa.html HYPERLINK https:/www.MedChemE/super-tdu-tfa.html Super-TDU HYPERLINK https:/www.MedChemE/super-tdu-tfa.html HYPERLINK https:/www.MedChemE/super-tdu-tfa.html TFACat. No.: HY-P1728A Cat. No.: HY-P1727ASuper-TDU (1-31) is a peptide of Super-TDU, whichis an inhibitor of YAP-TEADs, shows
21、 potentanti-tumor activity.Super-TDU TFA is a specific YAP antagonisttargeting YAP-TEADs interaction. Super-TDU TFAsuppresses tumor growth in gastric cancer mousemodel.Purity: 96.04%Clinical Data: No Development ReportedSize: 1 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPE
22、RLINK https:/www.MedChemE/ted-347.html TED-347Cat. No.: HY-125269 HYPERLINK https:/www.MedChemE/Verteporfin.html Verteporfin(CL 318952) Cat. No.: HY-B0146TED-347 is a potent, irreversible, covalent andallosteric inhibitor at YAP-TEAD protein-proteininteraction with an EC of 5.9 M for TEAD4Yap150prot
23、ein-protein interaction.Verteporfin (CL 318952) is a photosensitizer forphotodynamic therapy to eliminate the abnormalblood vessels in the eye associated withconditions such as age-related maculardegeneration. Verteporfin is a YAP inhibitorwhich disrupts YAP-TEAD interactions.Purity: 98.78%Clinical
24、Data: No Development ReportedSize: 10 mM 1 mL, 1 mg, 5 mg, 10 mg, 25 mg, 50 mgPurity: 99.58%Clinical Data: LaunchedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/vt103.html VT103 HYPERLINK https:/www.MedChemE/vt103.html HYPERLINK https:/www.MedChemE/vt107.html VT107Cat. N
25、o.: HY-134955 Cat. No.: HY-134957VT103, an analog of VT101, is an orally active andselective TEAD1 protein palmitoylation inhibitor.VT103 inhibits YAP/TAZ-TEAD promoted genetranscription, blocks TEAD auto-palmitoylation,and disrupts interaction between YAP/TAZ andTEAD.VT-107, as an analogous to VT10
26、4, is an orallyactive and potent pan-TEAD auto-palmitoylationinhibitor. VT-107 can be used for the research ofcancer.Purity: 99.21%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 99.98%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50
27、 mg, 100 mg HYPERLINK https:/www.MedChemE/yap-tead.html YAP-TEAD-IN-1 HYPERLINK https:/www.MedChemE/yap-tead.html HYPERLINK https:/www.MedChemE/yap-tead-tfa.html YAP-TEAD-IN-1 HYPERLINK https:/www.MedChemE/yap-tead-tfa.html HYPERLINK https:/www.MedChemE/yap-tead-tfa.html TFACat. No.: HY-P2244 Cat. No.: HY-P2244AYAP-TEAD-IN-1 is a potent and competitiveinhibitor of YAPTEAD interaction (IC =2550nM). YAP-TEAD-IN-1 is a 17mer pep
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2026中国消费电子行业产品创新与市场需求演变趋势报告
- 2026中国预制菜行业消费行为变迁与渠道变革趋势白皮书
- 2026中国新材料研发制造行业市场竞争态势及未来发展前景评估报告
- 2026中国体育行业市场现状赛事运营分析及投资评估体育产业发展研究报告
- 2026生物能源技术示范应用投资效益产业链规划分析报告
- 2026中国网络游戏平台用户增长驱动因素分析及游戏类型多元化战略指南
- 2026食品调味品行业市场发展趋势和投资布局规划分析研究规划
- 2026人工智能城市规划布局技术优化方案及应用案例实践与政策协同报告
- 2026中国生物医药外包服务行业市场格局与发展路径分析报告
- 湖南省长沙市望城区第二中学2026-2027学年高三上学期开学考试生物试卷
- LY/T 1188-2025便携式链锯导板
- 2026年医疗机构放射工作人员放射防护培训考试试题(附答案)
- 儿外科工作制度
- 套筒焊接施工方案(3篇)
- 物业报修管理制度
- 餐厅社交媒体运营方案
- 间隙感染的护理要点
- 2025中共杭州市委党校萧山区分校招聘事业人员1人备考题库附答案解析(夺冠)
- 护理教学查房的组织与实施试讲
- 2022供电营业厅标准化建设与改造项目管理手册
- 软件安全测试预案
评论
0/150
提交评论